Navigation Links
Gerresheimer Expands in the Global Pharmaceutical Plastic Business
Date:9/22/2009

DUSSELDORF, Germany, September 22 /PRNewswire-FirstCall/ -- The Gerresheimer Group expands its activities in the pharmaceutical plastic business with two strategically significant investments in the USA and Europe. This week the company is almost simultaneously opening a new research and development center for medical plastic systems in the USA as well as a new production center for pharmaceutical plastic packaging in Spain. "Plastics are increasingly gaining in importance within our highly specialized service portfolio for the international pharmaceutical industry," Gerresheimer AG CEO Dr. Axel Herberg says. "The pharmaceutical plastic business has meanwhile become the division with the highest growth rate, which we are continu-ing to expand systematically. These are crucial investments in the Gerresheimer Group's growth."

The new technological center in Peachtree City (Georgia/USA) is opening up a new dimension for the Group's flourishing business with American industrial clients from the pharmaceutical, diagnostics and medical technology industry. As a full service provider for medical plastic systems, Gerresheimer has upgraded the US location, which has until recently been limited to manufacturing, to become a comprehensively operating research, development and production center. In the American market the Group now has facilities at the front end of its customized serial production of entire product and process development comparable to those only available in Europe up to now. The product range in this field includes highly developed inhalation systems for the treatment of respiratory diseases as well as insulin pen systems, skin-prick aids and lancets for the diabetes sector, which is also growing steadily.

The newly opened plant in Masalaves in Spain (region of Valencia) is also highly significant with regard to the broad market of standardized pharmaceutical system packaging made of plastics. The plant is deemed to be the biggest production center of its kind in Southern Europe and is a significant strategic base for Gerresheimer there as well as in the Central European region. Pharmaceutical bottles and multifunctional dosage and closure systems, for example for eye drops, contact lens care products, nose sprays as well as tablets, are being produced there.

With the help of significant acquisitions, targeted investments and organic growth Gerresheimer has accelerated its plastics business during the past five years and developed it into an internationally leading market force. All in all, the company now possesses 15 locations in Europe, America and Asia in this sector. Both segments of the plastics division are continuing to attain above average growth rates. Accounting for a third of group sales, plastics have already become the largest growth area within the Gerresheimer Group.

About Gerresheimer

Gerresheimer employs around 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totaled EUR1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.

    Contact Press:
    Burkhard Lingenberg
    Director Corporate Communication & Marketing
    Phone +49-211-6181-250
    Fax   +49-211-6181-241
    e-mail b.lingenberg@gerresheimer.co

    Contact Investor Relations:
    Anke Linnartz
    Director Corporate Investor Relations
    Phone +49-211-6181-314
    Fax   +49-211-6181-121
    e-mail a.linnartz@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Standard & Poors Confirms Rating for Gerresheimer
2. Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed
3. Gerresheimer Continues Expansion Course
4. Blackstone Sells Gerresheimer Stake
5. Standard & Poors Raises Gerresheimer Rating to BB+
6. Gerresheimer Starts the Year Successfully in 2008
7. Gerhard Schulze New Chairman of the Supervisory Board of Gerresheimer AG
8. Gerresheimer Finalises Purchase of Spanish Company EDP
9. Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
10. Linnartz New Head of Investor Relations of Gerresheimer
11. Growth Trend for Gerresheimer Continues Unabated - Debt Reduction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... ... still in shock after receiving a $2,500 Academic Award from California Casualty . “This ... She thinks the coming week is going to be a very joyful for her classroom. ... students.” , The award will allow the 4th grade teacher at Tumwater Hill Elementary School ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy ... resolve the pending litigation between itself and 1800 Vending DBA Healthy You Vending. ... “I am thrilled to announce that we have now reached a settlement agreement ...
(Date:3/26/2017)... (PRWEB) , ... March 26, 2017 , ... ... worldwide to receive the RealSelf 100 Award, a prestigious award honoring the top ... procedures and to find and connect with doctors and clinics. , In 2016, ...
(Date:3/24/2017)... York, NY (PRWEB) , ... March 24, 2017 ... ... campaign: “Fighting Infection,” which will spark a conversation on the current obstacles facing ... the number of completely preventable deaths caused by these infections. , The ...
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is ... 9618 Huebner Road. The clinic is the group’s 7th location in San Antonio and ... Higgins, PT, will provide care from the clinic, which opened March 22, 2017. ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... India , March 24, 2017 Abdominal Aortic Aneurysm Repair ... million by 2022, Globally, registering a CAGR of 5.1% from 2016 to 2022. The ... projected to dominate the market during the study period. ... ... ...
(Date:3/24/2017)... -- Research and Markets has announced the addition ... report to their offering. ... Pain Management in the U.S.: ... physical pain, emphasizing consumer survey analysis, including trends over time. ... who have selected illnesses/conditions strongly associated with physical pain and ...
(Date:3/24/2017)... FinancialBuzz.com News Commentary   ... Medical cannabis products around the world are projected to gain popularity. ... cannabis market will reach a value of USD 55.8 billion by 2025. ... new growing industry. By the end of 2016, 28 states have now ... More conservative states like Arkansas and ...
Breaking Medicine Technology: